XORTX Therapeutics Initiates Reverse Stock Split to Maintain Exchange Listings
XORTX Therapeutics is taking decisive action to address regulatory pressures. The biotechnology firm will implement a 1-for-5 reverse stock split ...
Tag: XORTX Therapeutics
XORTX Therapeutics Faces Crucial Nasdaq Compliance Test
The coming weeks present a critical juncture for XORTX Therapeutics as it works to maintain its position on the Nasdaq ...
XORTX Therapeutics Initiates Reverse Stock Split to Maintain Nasdaq Listing
In a strategic move to preserve its position on the Nasdaq exchange, XORTX Therapeutics is implementing a reverse stock split. ...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
